Additional Information Will News Today

08 Dec 2023 Cadeler announces signing of EUR 550 million Green Loan and Guarantee Facilities Copenhagen, December 8, 2023. Today, Cadeler A/S announced the signing of the...

– Merger to create NASDAQ-listed, commercial-stage AI-Enabled medical technology company focused on bringing FDA-cleared Brain Network Analytics platform...

Announced a definitive merger agreement to acquire Pangiam in an all-stock transaction, combining facial recognition and advanced biometrics with BigBear.ai’s computer vision capabilities to...

COLUMBIA, Md., Nov. 06, 2023 -- BigBear.ai , a leading provider of AI-enabled business intelligence solutions, today announced a definitive merger agreement to acquire Pangiam Intermediate...

Acquires F351, a Phase 3 Drug to Treat Fibrosis Will Acquire Controlling Interest in Continent, a China-Based Commercial Pharma Company, from the GNI Group in Subsequent Transaction Announces $7.5... | December 27, 2022

Acquires F351, a Phase 3 Drug to Treat Fibrosis Will Acquire Controlling Interest in Continent, a China-Based Commercial Pharma Company, from the GNI Group in Subsequent Transaction Announces $7.5

/PRNewswire/ -- Disc Medicine, a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel treatments for...

/PRNewswire/ -- Disc Medicine, a clinical-stage biotechnology company dedicated to the discovery and development of novel therapeutic candidates for the...

Secured Initial Volume Order from Siemens Mobility for the Class I Rail 900 MHz NetworkEntered into Definitive Merger Agreement to Acquire Airobotics, a Leading Developer of Autonomous Drone SystemsConference

BASKING RIDGE, N.J. and SAN DIEGO, July 06, 2022 -- Caladrius Biosciences, Inc. , a clinical-stage biopharmaceutical company developing innovative therapies designed to treat or reverse... | July 6, 2022